TAK-243 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndromes With Increased Blasts
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Baylor College of Medicine
Fred Hutchinson Cancer Center